Literature DB >> 5870913

The effect of 4-amino-5-imidazolecarboxamide on the synergistic antineoplastic activity of 6-chloropurine and azaserine.

A C Sartorelli, B A Booth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5870913     DOI： 10.1007/bf02150818

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


× No keyword cloud information.
  6 in total

1.  REACTIONS OF RIBONUCLEOTIDE DERIVATIVES OF PURINE ANALOGUES AT THE CATALYTIC SITE OF INOSINE 5'-PHOSPHATE DEHYDROGENASE.

Authors:  A HAMPTON
Journal:  J Biol Chem       Date:  1963-09       Impact factor: 5.157

2.  Antineoplastic activity of combinations of 6-chloropurine and azaserine.

Authors:  A C SARTORELLI; B A BOOTH
Journal:  Cancer Res       Date:  1960-02       Impact factor: 12.701

3.  Effects of combinations of azaserine and of 6-diazo-5-oxo-L-norleucine with purine analogs and other antimetabolites on the growth of two mouse mammary carcinomas.

Authors:  G S TARNOWSKI; C C STOCK
Journal:  Cancer Res       Date:  1957-11       Impact factor: 12.701

4.  In vitro incorporation of glycine-2-C14 into purines and proteins.

Authors:  G A LEPAGE
Journal:  Cancer Res       Date:  1953-02       Impact factor: 12.701

5.  A comparative study of 6-diazo-5-oxo-L-norleucine and O-diazoacety-L-serine on sarcoma 180.

Authors:  D A CLARKE; H C REILLY; C C STOCK
Journal:  Antibiot Chemother (Northfield)       Date:  1957-12

Review 6.  Approaches to the combination chemotherapy of transplantable neoplasms.

Authors:  A C Sartorelli
Journal:  Prog Exp Tumor Res       Date:  1965
  6 in total
  1 in total

1.  Modulation of the cytotoxic mechanism of 6-thioguanine by 4-amino-5-imidazolecarboxamide.

Authors:  J Maybaum; C W Morgans; P Ting; C E Rogers
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.